United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 10, 2026 · Filed Sep 11, 2026

On Sep 10, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$502.35 for US$4.77M under a trading plan, leaving 324,443 shares. Filed Sep 11, 2026 (Form 4).

Sold
9,500 shares
Price
US$502.35 average (US$498.44 to US$508.80)
Value
US$4.77M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 10, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 10, 2026Common StockSale120US$498.44333,823Indirect
Sep 10, 2026Common StockSale1,788US$499.75332,035Indirect
Sep 10, 2026Common StockSale1,372US$500.58330,663Indirect
Sep 10, 2026Common StockSale2,244US$501.88328,419Indirect
Sep 10, 2026Common StockSale1,536US$502.80326,883Indirect
Sep 10, 2026Common StockSale578US$503.76326,305Indirect
Sep 10, 2026Common StockSale702US$505.03325,603Indirect
Sep 10, 2026Common StockSale600US$505.94325,003Indirect
Sep 10, 2026Common StockSale280US$506.76324,723Indirect
Sep 10, 2026Common StockSale280US$508.80324,443Indirect

Source

View original at SEC

Related